Use of TCR alpha(+)beta(+)/CD19(+)-Depleted Haploidentical Hematopoietic Stem Cell Transplant Is a Viable Option in Patients With Primary Immune Deficiency Without Matched Sibling Donor

导出原文传递

翻译打印收藏纠错

作者： Brettig, Tim ^[1] ; Smart, Joanne ^[2] ; Choo, Sharon ^[3] ; Mechinaud, Francoise ; Mitchell, Richard ; Raj, Trisha Soosay ; Cole, Theresa

作者单位： Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia ^[1] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia ^[2] Royal Childrens Hosp, Dept Allergy & Immunol, Melbourne, Vic, Australia ^[3]

关键词 TCR alpha+beta+/CD19+-depleted haploidentical HSCT Primary immune deficiency Immune reconstitution

发布时间 2020-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Clinical Immunology

2019年39卷5期

505-511页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Use of TCR alpha(+)beta(+)/CD19(+)-Depleted Haploidentical Hematopoietic Stem Cell Transplant Is a Viable Option in Patients With Primary Immune Deficiency Without Matched Sibling Donor

Journal of Clinical Immunology

相似文献

Journal of Clinical Immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of TCR alpha(+)beta(+)/CD19(+)-Depleted Haploidentical Hematopoietic Stem Cell Transplant Is a Viable Option in Patients With Primary Immune Deficiency Without Matched Sibling Donor

Journal of Clinical Immunology

相似文献

Journal of Clinical Immunology

相关期刊

检索历史清除